focus -WSS

focus

author：comprehensive 2025-10-02 22:56:39 - browse：46

Most everything is looking up for Orexo, the company reported on its second quarter earnings call on Tuesday. That is, everything but its digital therapies pipeline.

The Swedish pharmaceutical company, which makes almost all of its money from U.S. sales of its drug for opioid dependence, notched a number of important victories in the quarter: It successfully defended its patents in a case against Sun Pharmaceuticals, it resolved a packaging issue that was holding up the approval of its long-acting rescue medication, and it grew revenues for Zubsolv, its most important product. The company trimmed its losses to 12.6 million SEK, or $1.2 million, and executives reported that with fewer one-time expenses on the horizon, profitability was “in sight.”

“We are at an exciting turning point for the company and I hope our self confidence and optimism is something that you can share,” CEO Nikolaj Sørensen said on the company’s earnings call while cautioning that “there’s a lot more work to be done.”

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Jerome Adams on the need for new antivirals for Covid
Next article： Drinking water from half of US faucets contains PFAS: Study

hotspot

WSS

Rare Northern Lights show in US this week: Where and how to see it

David Sabatini, ex

Submersible on Titanic tour reported missing off Newfoundland with 5 people aboard

Rare Northern Lights show in US this week: Where and how to see it

Do more moles mean more problems? Not so, says new study

Titanic submersible victims' family mourns: 'Enormous tragedy and devastation'

hotspot

focus

entertainment

Heart attack and stroke risk calculators need revising

North Korean leader's powerful sister says warplanes repelled US spy plane

23andMe had bad news about my health. I wish a person had delivered it

David Sabatini, ex

ChatGPT in medicine: STAT answers readers' burning questions

Readout Newsletter: Moderna bird flu vaccine, Biohaven, ASCO

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Startling documents reveal new facets of Sacklers' opioid empire

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Report: NIH

explore

Titanic submersible victims' family mourns: 'Enormous tragedy and devastation'

Addiction doctors spar with methadone clinics over legislation

Father who lunged at Larry Nassar comforted by deputy who pinned him down: 'I understand'

Why Titanic fascinates society, still drawing tours to the wreckage

Startling documents reveal new facets of Sacklers' opioid empire

Addiction doctors spar with methadone clinics over legislation

explore

focus

hotspot

hotspot